PILMA Letter of Opposition to 340B Expansion in New York.
The Honorable Kathy Hochul Governor of New York New York State Capitol Building Albany, NY 12224 Dear Governor Hochul, On behalf of the Pharmaceutical Industry Labor-Management Association (PILMA), I write to express strong opposition to the inclusion of 340B expansion language in the final New York State budget, including the language reflected in A.6222 (Paulin) […]
PILMA Letter on 340B Legislation in Minnesota
February 25, 2026 Senator Erin Murphy 95 University Ave W Minnesota Senate Building, Room 3113 St. Paul, MN 55115 Representative Lisa Demuth C Centennial Office Building, 2nd Floor St. Paul, MN 55115 Dear Majority Leader Murphy and Speaker Demuth: On behalf of the Pharmaceutical Industry Labor-Management Association (PILMA), a labor-management partnership representing unions and biopharmaceutical […]
PILMA Letter on Virginia PDAB Legislation
The Honorable Abigail Spanberger Governor of Virginia 1111 East Broad Street Richmond, VA 23219 Dear Governor Spanberger, On behalf of the Pharmaceutical Industry Labor-Management Association (PILMA), we respectfully urge you to oppose HB 483 / SB 271, legislation that would establish a Prescription Drug Affordability Board. We recognize that the cost of prescription drugs is […]
PILMA Applauds Bipartisan PBM Reform in Congressional Appropriations Package
February 3, 2026 Washington, D.C. – The Pharmaceutical Industry Labor-Management Association (PILMA) applauds Congress for passing critical pharmacy benefit manager (PBM) reform legislation as part of the bipartisan spending package now headed to the President’s desk. “After years of advocacy, meaningful PBM reform has finally crossed the finish line,” said AJ Stokes, PILMA’s Executive Director. […]
PILMA Calls for PBM Reform in the 119th Congress
The Honorable Brett Guthrie, Chairman House Committee on Energy and Commerce 2161 Rayburn House Office Building, Washington, DC 20515 The Honorable Representative Frank Pallone, Ranking Member House Committee on Energy and Commerce 2125 Rayburn House Office Building, Washington, DC 20515 The Honorable Representative Jason Smith, Chairman House Committee on Ways and Means 1011 Longworth House Office Building, Washington, DC 20515 […]
PRESS RELEASE PILMA Applauds Bipartisan PBM Reform Legislation, Urges Swift Action Before Year’s End
December 5, 2025 FOR IMMEDIATE RELEASE PILMA Applauds Bipartisan PBM Reform Legislation, Urges Swift Action Before Year’s End Washington, D.C. – The Pharmaceutical Industry Labor-Management Association (PILMA) today applauded Senate Finance Committee Chairman Mike Crapo (R-Idaho) and Ranking Member Ron Wyden (D-Oregon) for introducing the bipartisan Pharmacy Benefit Manager (PBM) Price Transparency and Accountability Act. […]
Senate HELP: PBM transparency and reform letter
December 3, 2025 The Honorable Bill Cassidy, ChairmanSenate Committee on Health, Education, Labor & Pensions428 Senate Dirksen Office Building, Washington, DC, 20510 The Honorable Bernie Sanders, Ranking MemberSenate Committee on Health, Education, Labor & Pensions428 Senate Dirksen Office Building, Washington, DC, 20510 Dear Senators Cassidy and Sanders, We write today on behalf of the Pharmaceutical […]
A $416 Million Hit to Union Workers: New Research Highlights How the 340B Program Drives Up Costs for Taft-Hartley Plans
A recent study found that a little-known federal program may be driving up union healthcare costs by as much as $416 million per year. The 340B program was created more than 30 years ago to help safety-net providers serve low-income communities by offering prescription drugs at steep discounts. Over time, however, the program has expanded […]
Foreign Reference Pricing Threatens Union Jobs, American Global Leadership
FOR IMMEDIATE RELEASEAugust 7, 2025 Importing foreign prices would undermine life science innovation, eliminate union jobs, and cede ground to China The Pharmaceutical Industry Labor-Management Association (PILMA) expresses deep concern over recent White House actions that aim to implement a “Most Favored Nation” (MFN) pricing policy for prescription drugs. This misguided approach poses a serious […]
Letter to HELP Committee on PBMs
July 31, 2025 The Honorable Bill Cassidy, Chairman Senate Committee on Health, Education, Labor and Pensions United States Senate Washington, DC 20510 The Honorable Bernie Sanders, Ranking Member Senate Committee on Health, Education, Labor and Pensions United States Senate Washington, DC 20510 Dear Chairman Cassidy and Ranking Member Sanders, On behalf of the Pharmaceutical Industry Labor-Management Association (PILMA) […]